230 related articles for article (PubMed ID: 32959628)
1. Validity of presepsin for the diagnosis and prognosis of sepsis in elderly patients admitted to the Intensive Care Unit.
Wang S; Ruan WQ; Yu Z; Zhao X; Chen ZX; Li Q
Minerva Anestesiol; 2020 Nov; 86(11):1170-1179. PubMed ID: 32959628
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment.
Behnes M; Bertsch T; Lepiorz D; Lang S; Trinkmann F; Brueckmann M; Borggrefe M; Hoffmann U
Crit Care; 2014 Sep; 18(5):507. PubMed ID: 25190134
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic utility of presepsin for sepsis in very elderly patients in the emergency department.
Ruangsomboon O; Panjaikaew P; Monsomboon A; Chakorn T; Permpikul C; Limsuwat C
Clin Chim Acta; 2020 Nov; 510():723-732. PubMed ID: 32946797
[TBL] [Abstract][Full Text] [Related]
4. Clinical Value of Presepsin in Comparison to hsCRP as a Monitoring and Early Prognostic Marker for Sepsis in Critically Ill Patients.
Hassan EA; Abdel Rehim AS; Ahmed AO; Abdullahtif H; Attia A
Medicina (Kaunas); 2019 Feb; 55(2):. PubMed ID: 30717340
[TBL] [Abstract][Full Text] [Related]
5. Presepsin a Diagnostic Marker for Sepsis in Intensive Care Unit Patients.
Amer HA; Ghareeb H; Lotfy NM; El-Azizi NO; Mahmoud AM
Egypt J Immunol; 2016 Jun; 23(2):109-118. PubMed ID: 28502138
[TBL] [Abstract][Full Text] [Related]
6. Utility of sTREM-1 and Presepsin (sCD14-ST) as Diagnostic and Prognostic Markers of Sepsis.
Chen M; Zhu Y
Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255294
[TBL] [Abstract][Full Text] [Related]
7. Presepsin values and prognostic nutritional index predict mortality in intensive care unit patients with sepsis: a pilot study.
Shimoyama Y; Umegaki O; Kadono N; Minami T
BMC Res Notes; 2021 Jun; 14(1):245. PubMed ID: 34193271
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of presepsin (sCD14-ST) as a biomarker of infection and sepsis in the emergency department.
de Guadiana Romualdo LG; Torrella PE; Acebes SR; Otón MDA; Sánchez RJ; Holgado AH; Santos EJ; Freire AO
Clin Chim Acta; 2017 Jan; 464():6-11. PubMed ID: 27823951
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic value of presepsin vs. established biomarkers in critically ill patients with sepsis or systemic inflammatory response syndrome.
Brodska H; Valenta J; Pelinkova K; Stach Z; Sachl R; Balik M; Zima T; Drabek T
Clin Chem Lab Med; 2018 Mar; 56(4):658-668. PubMed ID: 29176018
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Utility of Procalcitonin, Presepsin, and the VACO Index for Predicting 30-day Mortality in Hospitalized COVID-19 Patients.
Park M; Hur M; Kim H; Lee CH; Lee JH; Kim HW; Nam M
Ann Lab Med; 2022 Jul; 42(4):406-414. PubMed ID: 35177561
[TBL] [Abstract][Full Text] [Related]
11. Presepsin vs Procalcitonin as Predictors of Sepsis Outcome.
Narendra S; Wyawahare M; Adole PS
J Assoc Physicians India; 2022 Nov; 70(11):11-12. PubMed ID: 37355942
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study.
Ulla M; Pizzolato E; Lucchiari M; Loiacono M; Soardo F; Forno D; Morello F; Lupia E; Moiraghi C; Mengozzi G; Battista S
Crit Care; 2013 Jul; 17(4):R168. PubMed ID: 23899120
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean population.
Kweon OJ; Choi JH; Park SK; Park AJ
J Crit Care; 2014 Dec; 29(6):965-70. PubMed ID: 25042676
[TBL] [Abstract][Full Text] [Related]
14. Soluble CD14 Subtype-A New Biomarker in Predicting the Outcome of Critically Ill Septic Patients.
Matera G; Quirino A; Peronace C; Settembre P; Marano V; Loria MT; Marascio N; Galati L; Barreca GS; Giancotti A; Amantea B; Liberto MC; Focà A
Am J Med Sci; 2017 Jun; 353(6):543-551. PubMed ID: 28641717
[TBL] [Abstract][Full Text] [Related]
15. The utility of presepsin in diagnosis and risk stratification for the emergency patients with sepsis.
Lu B; Zhang Y; Li C; Liu C; Yao Y; Su M; Shou S
Am J Emerg Med; 2018 Aug; 36(8):1341-1345. PubMed ID: 29276032
[TBL] [Abstract][Full Text] [Related]
16. Validity of biomarkers in screening for neonatal sepsis - A single center -hospital based study.
Rashwan NI; Hassan MH; Mohey El-Deen ZM; Ahmed AE
Pediatr Neonatol; 2019 Apr; 60(2):149-155. PubMed ID: 29895470
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 Levels Act as a Diagnostic Marker for Infection and a Prognostic Marker in Patients with Organ Dysfunction in Intensive Care Units.
Takahashi W; Nakada TA; Yazaki M; Oda S
Shock; 2016 Sep; 46(3):254-60. PubMed ID: 27172160
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic value of presepsin and procalcitonin in non-infectious organ failure, sepsis, and septic shock: a prospective observational study according to the Sepsis-3 definitions.
Lee S; Song J; Park DW; Seok H; Ahn S; Kim J; Park J; Cho HJ; Moon S
BMC Infect Dis; 2022 Jan; 22(1):8. PubMed ID: 34983420
[TBL] [Abstract][Full Text] [Related]
19. Presepsin:albumin ratio and C-reactive protein:albumin ratio as novel sepsis-based prognostic scores : A retrospective study.
Kaplan M; Duzenli T; Tanoglu A; Cakir Guney B; Onal Tastan Y; Bicer HS
Wien Klin Wochenschr; 2020 Apr; 132(7-8):182-187. PubMed ID: 32060723
[TBL] [Abstract][Full Text] [Related]
20. Are presepsin and resistin better markers for bacterial infection in patients with decompensated liver cirrhosis?
Fischer P; Grigoras C; Bugariu A; Nicoara-Farcau O; Stefanescu H; Benea A; Hadade A; Margarit S; Sparchez Z; Tantau M; Ionescu D; Procopet B
Dig Liver Dis; 2019 Dec; 51(12):1685-1691. PubMed ID: 31221548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
